Publications by authors named "Sarah Hockley"

Claim this Profile
E
Erratum to "Gene expression profiles modulated by the human carcinogen aristolochic acid I in human cancer cells and their dependence on TP53" [Toxicol. Appl. Pharmacol. 232(1) (2008) 86-98].
Maria L Simões, Sarah L Hockley, Tanja Schwerdtle, Gonçalo Gamboa da Costa, Heinz H Schmeiser

Toxicol Appl Pharmacol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphoma.
Sarah L Hockley, Monica Else, Alison Morilla, Andrew Wotherspoon, Claire Dearden

Br J Haematol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical impact and molecular biology of del(17p) in multiple myeloma treated with conventional or thalidomide-based therapy.
Kevin D Boyd, Fiona M Ross, William J Tapper, Laura Chiecchio, GianPaolo Dagrada, Sarah L Hockley

Genes Chromosomes Cancer· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trial.
David Gonzalez, Pilar Martinez, Rachel Wade, Sarah Hockley, David Oscier

J Clin Oncol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insight into the molecular pathogenesis of hairy cell leukaemia, hairy cell leukaemia variant and splenic marginal zone lymphoma, provided by the analysis of their IGH rearrangements and somatic hypermutation patterns.
Sarah L Hockley, Stavroula Giannouli, Alison Morilla, Andrew Wotherspoon, Gareth J Morgan

Br J Haematol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interlaboratory and interplatform comparison of microarray gene expression analysis of HepG2 cells exposed to benzo(a)pyrene.
Sarah L Hockley, Karen Mathijs, Yvonne C M Staal, Daniel Brewer, Ian Giddings

OMICS· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profiles modulated by the human carcinogen aristolochic acid I in human cancer cells and their dependence on TP53.
Maria L Simões, Sarah L Hockley, Tanja Schwerdtle, Gonçalo Gamboa da Costa, Heinz H Schmeiser

Toxicol Appl Pharmacol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification through microarray gene expression analysis of cellular responses to benzo(a)pyrene and its diol-epoxide that are dependent or independent of p53.
Sarah L Hockley, Volker M Arlt, Gunnar Jahnke, Andrea Hartwig, Ian Giddings

Carcinogenesis· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AHR- and DNA-damage-mediated gene expression responses induced by benzo(a)pyrene in human cell lines.
Sarah L Hockley, Volker M Arlt, Daniel Brewer, Robert Te Poele, Paul Workman

Chem Res Toxicol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time- and concentration-dependent changes in gene expression induced by benzo(a)pyrene in two human cell lines, MCF-7 and HepG2.
Sarah L Hockley, Volker M Arlt, Daniel Brewer, Ian Giddings, David H Phillips

BMC Genomics· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide linkage screen for testicular germ cell tumour susceptibility loci.
Gillian P Crockford, Rachel Linger, Sarah Hockley, Darshna Dudakia, Lola Johnson

Hum Mol Genet· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis